One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Novel risk factors for atrial fibrillation, conduction disturbances, sudden coronary death, and device infection
Filippo Crea
doi : 10.1093/eurheartj/ehac734
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4853–4857
Meet the European Society of Cardiology Gold Medallists 2022
Judith Ozkan
doi : 10.1093/eurheartj/ehac602
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4858–4860
New honour in memory of one of the giants of cardiology goes to Hannover Medical School
Judith Ozkan
doi : 10.1093/eurheartj/ehac557
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4861–4863
Remembering Desmond Julian and the first edition of the European Heart Journal
Judith Ozkan
doi : 10.1093/eurheartj/ehac592
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4864–4866
European Heart Journal makes an impact at the ESC Congress in Barcelona
Judith Ozkan
doi : 10.1093/eurheartj/ehac555
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4867–4869
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide?
Daniela Pedicino, Massimo Volpe
doi : 10.1093/eurheartj/ehac581
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4870–4871
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
Reinoud E Knops, Shari Pepplinkhuizen, Peter Paul H M Delnoy, Lucas V A Boersma, Juergen Kuschyk, Mikhael F El-Chami, Hendrik Bonnemeier, Elijah R Behr, Tom F Brouwer, Stefan Kaab, Suneet Mittal, Anne-Floor B E Quast, Willeke van der Stuijt, Lonneke Smeding, Jolien A de Veld, Jan G P Tijssen, Nick R Bijsterveld, Sergio Richter, Marc A Brouwer, Joris R de Groot, Kirsten M Kooiman, Pier D Lambiase, Petr Neuzil, Kevin Vernooy, Marco Alings, Timothy R Betts, Frank A L E Bracke, Martin C Burke, Jonas S S G de Jong, David J Wright, Ward P J Jansen, Zachary I Whinnett, Peter Nordbeck, Michael Knaut, Berit T Philbert, Jurren M van Opstal, Alexandru B Chicos, Cornelis P Allaart, Alida E Borger van der Burg, Jose M Dizon, Marc A Miller, Dmitry Nemirovsky, Ralf Surber, Gaurav A Upadhyay, Raul Weiss, Anouk de Weger, Arthur A M Wilde, Louise R A Olde Nordkamp On behalf of the PRAETORIAN Investigators
doi : 10.1093/eurheartj/ehac496
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4872–4883
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD (TV-ICD) therapy. The PRAETORIAN trial demonstrated that the S-ICD is non-inferior to the TV-ICD with regard to the combined primary endpoint of inappropriate shocks and complications. This prespecified secondary analysis evaluates all complications in the PRAETORIAN trial.
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD (TV-ICD) therapy. The PRAETORIAN trial demonstrated that the S-ICD is non-inferior to the TV-ICD with regard to the combined primary endpoint of inappropriate shocks and complications. This prespecified secondary analysis evaluates all complications in the PRAETORIAN trial.
Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
doi : 10.1093/eurheartj/ehac652
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4884–4886
Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study
Rodrigue Garcia, Eloi Marijon, Nicole Karam, Kumar Narayanan, Frédéric Anselme, Olivier Césari, Laure Champ-Rigot, Vladimir Manenti, Raphael Martins, Etienne Puymirat, Jean Ferrières, François Schiele, Tabassome Simon, Nicolas Danchin
doi : 10.1093/eurheartj/ehac579
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4887–4896
Sudden cardiac arrest remains a major complication of acute myocardial infarction (AMI) and is frequently related to ventricular fibrillation (VF). Incidence and impact of VF among patients hospitalized for AMI were evaluated.
How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation
Lauri Holmstrom, Sumeet S Chugh
doi : 10.1093/eurheartj/ehac578
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4897–4898
Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing
Pascal B Meyre, Steffen Blum, Elisa Hennings, Stefanie Aeschbacher, Tobias Reichlin, Nicolas Rodondi, Jürg H Beer, Annina Stauber, Andreas Müller, Tim Sinnecker, Elisavet Moutzouri, Rebecca E Paladini, Giorgio Moschovitis, Giulio Conte, Angelo Auricchio, Alexandra Ramadani, Matthias Schwenkglenks, Leo H Bonati, Michael Kühne, Stefan Osswald, David Conen
doi : 10.1093/eurheartj/ehac587
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4899–4908
To determine the risk of subsequent adverse clinical outcomes in anticoagulated patients with atrial fibrillation (AF) who experienced a new bleeding event.
Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem
Josephine Harrington, Christopher B Granger
doi : 10.1093/eurheartj/ehac627
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4909–4911
Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances
Aviram Akuka, Niv Ben-Shabat, Abdulla Watad, Avishai M Tsur, Scott Ehrenberg, Dennis McGonagle, Doron Comaneshter, Roy Beinart, Arnon D Cohen, Howard Amital Author Notes
doi : 10.1093/eurheartj/ehac516
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4912–4919
Anti-Ro/La autoantibodies are especially prevalent in autoimmune diseases but are also relatively frequent in healthy adults. Their arrhythmogenic effect on the immature cardiac conductive system is well established, with substantial evidence demonstrating an increased risk for congenital atrioventricular block in neonates of seropositive mothers.
Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the ‘dark side of the immune’
Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
doi : 10.1093/eurheartj/ehac575
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4920–4922
Plaque histology and myocardial disease in sudden coronary death: the Fingesture study
Lauri Holmström, Samuli Juntunen, Juha Vähätalo, Lasse Pakanen, Kari Kaikkonen, Anette Haukilahti, Tuomas Kenttä, Jani Tikkanen, Ville Viitasalo, Juha Perkiömäki, Heikki Huikuri, Robert J Myerburg, Juhani Junttila
doi : 10.1093/eurheartj/ehac533
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4923–4930
At least 50% of deaths due to coronary artery disease (CAD) are sudden cardiac deaths (SCDs), but the role of acute plaque complications on the incidence of sudden death in CAD is somewhat unclear. The present study aimed to investigate plaque histology and concomitant myocardial disease in sudden coronary death.
Ischaemic myocardial fibrosis is the villain of sudden coronary death
Gaetano Thiene
doi : 10.1093/eurheartj/ehac571
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4931–4932
Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation
Anthony L Lin, Gregory Nah, Janet J Tang, Eric Vittinghoff, Thomas A Dewland, Gregory M Marcus
doi : 10.1093/eurheartj/ehac558
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4933–4942
Atrial fibrillation (AF) is now regarded as a preventable disease, requiring a search for modifiable risk factors. With legalization of cannabis and more lenient laws regarding the use of other illicit substances, investigation into the potential effects of methamphetamine, cocaine, opiate, and cannabis exposure on incident AF is needed.
Drug abuse and risk of atrial fibrillation: a neglected association
Monika Gawałko, Prashanthan Sanders
doi : 10.1093/eurheartj/ehac614
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4943–4945
Risk factors for cardiac implantable electronic device infections: a nationwide Danish study
Thomas Olsen, Ole Dan Jørgensen, Jens Cosedis Nielsen, Anna Margrethe Thøgersen, Berit Thornvig Philbert, Maria Hee Jung Park Frausing, Niels Christian Foldager Sandgaard, Jens Brock Johansen
doi : 10.1093/eurheartj/ehac576
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4946–4956
Cardiac implantable electronic device (CIED) infection is a severe complication to modern management of cardiac arrhythmias. The CIED type and the type of surgery are recognized as risk factors for CIED infections, but knowledge of patient-related risk factors is scarce.
Big data from the Danish Pacemaker and ICD Register
Haran Burri
doi : 10.1093/eurheartj/ehac574
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4957–4959
Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice
Emanuele Monda, Michele Lioncino, Giuseppe Limongelli
doi : 10.1093/eurheartj/ehac538
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Page 4960
Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models
Julia Cadrin-Tourigny, Laurens P Bosman, Cynthia A James
doi : 10.1093/eurheartj/ehac562
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Pages 4961–4962
Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage
Yanlin Yang, Lin Xie, Hong Qian, Kaijun Cui, Ke Lin
doi : 10.1093/eurheartj/ehac580
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Page 4963
Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens
Kensaku Nishihira, Yoshisato Shibata, Yujiro Asada
doi : 10.1093/eurheartj/ehac509
European Heart Journal, Volume 43, Issue 47, 14 December 2022, Page 4964
